Working... Menu

Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease (MAPUS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01951326
Recruitment Status : Active, not recruiting
First Posted : September 26, 2013
Last Update Posted : March 1, 2019
Information provided by (Responsible Party):
RedHill Biopharma Limited

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : December 2018
  Estimated Study Completion Date : April 2019